|
DEDD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.633500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.205600E-04 |
| Normal-vs-Stage2 |
3.280600E-03 |
| Normal-vs-Stage3 |
1.906550E-01 |
| Normal-vs-Stage4 |
2.428000E-01 |
| Stage1-vs-Stage2 |
8.586800E-01 |
| Stage1-vs-Stage3 |
1.743820E-01 |
| Stage1-vs-Stage4 |
7.708600E-01 |
| Stage2-vs-Stage3 |
2.503600E-01 |
| Stage2-vs-Stage4 |
7.179000E-01 |
| Stage3-vs-Stage4 |
6.374800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.423900E-04 |
| Normal-vs-AfricanAmerican |
3.384800E-03 |
| Normal-vs-Asian |
4.416000E-02 |
| Caucasian-vs-AfricanAmerican |
8.526200E-01 |
| Caucasian-vs-Asian |
8.772400E-01 |
| AfricanAmerican-vs-Asian |
9.151600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.43869999999591E-05 |
| Normal-vs-Female |
2.761800E-01 |
| Male-vs-Female |
1.054120E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.417840E-02 |
| Normal-vs-Extreme_Weight |
1.761280E-04 |
| Normal-vs-Obese |
1.732110E-02 |
| Normal-vs-Extreme_Obese |
1.498700E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.257200E-01 |
| Normal_Weight-vs-Obese |
7.792800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.253000E-01 |
| Extreme_Weight-vs-Obese |
2.273200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.721400E-01 |
| Obese-vs-Extreme_Obese |
2.495000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.016000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.368100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.09239999999777E-05 |
| Normal-vs-Age(81-100Yrs) |
1.60609999999561E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.084000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.863900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.594700E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.481550E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.522200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.334400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.042980E-03 |
| Normal-VS-Type2 PRCC |
2.47649999995936E-06 |
| Normal-VS-KIRP CIMP |
5.234000E-01 |
| Normal-VS-Unclassified PRCC |
6.776300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.388200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.036000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.651000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.456400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.678500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.025400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.64340000000196E-06 |
| Normal-vs-N1 |
8.348400E-01 |
| Normal-vs-N2 |
9.369600E-01 |
| N0-vs-N1 |
1.395730E-02 |
| N0-vs-N2 |
3.779200E-01 |
| N1-vs-N2 |
1.000000E+00 |
|
|
